Loading company…
Zenshine develops small-molecule drugs for cancer, viral infections, and autoimmune diseases.
Zenshine is a biopharmaceutical company researching and developing small-molecule drugs for cancer, viral infections, and autoimmune diseases. Its pipeline includes ZX-4081, ZX-101A, ZX-7101A, and ZX-3000; ZX-101A was approved by the US FDA for clinical trials in 2020. Founded in 2018, the company is based in Nanjing, China, with branches in Beijing and Hangzhou. In October 2025, it raised venture funding from Zbjl Capital, Ennovation Ventures, China Capital Management, In Capital, Jingjie Investment, Proxima Ventures, Tailong VC, and an individual investor.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in